KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silicon Laboratories (SLAB) Common Equity (2016 - 2026)

Silicon Laboratories has reported Common Equity over the past 17 years, most recently at $1.1 billion for Q1 2026.

  • For Q1 2026, Common Equity rose 1.33% year-over-year to $1.1 billion; the TTM value through Jan 2026 reached $1.1 billion, up 1.33%, while the annual FY2026 figure was $1.1 billion, 1.33% up from the prior year.
  • Common Equity for Q1 2026 was $1.1 billion at Silicon Laboratories, up from $1.1 billion in the prior quarter.
  • Over five years, Common Equity peaked at $2.2 billion in Q1 2022 and troughed at $1.1 billion in Q3 2025.
  • A 5-year average of $1.3 billion and a median of $1.2 billion in 2023 define the central range for Common Equity.
  • On a YoY basis, Common Equity climbed as much as 84.39% in 2022 and fell as far as 41.39% in 2022.
  • Year by year, Common Equity stood at $1.4 billion in 2022, then decreased by 13.97% to $1.2 billion in 2023, then decreased by 10.64% to $1.1 billion in 2024, then dropped by 0.86% to $1.1 billion in 2025, then rose by 2.21% to $1.1 billion in 2026.
  • Business Quant data shows Common Equity for SLAB at $1.1 billion in Q1 2026, $1.1 billion in Q4 2025, and $1.1 billion in Q3 2025.